| ORIGINAL ARTICLE |
|
| Year : 2011 | Volume
: 3
| Issue : 12 | Page : 557-561 |
|
|
Incidence of temonera, sulphuhydryl variables and cefotaximase genes associated with β-lactamase producing escherichia coli in clinical isolates
Ibeh Nnana Isaiah1, Bikwe Thomas Nche2, Ibeh Georgina Nwagu3, Ibeh Isaiah Nwagu4
1 Department of Medical Microbiology, Federal Medical Centre Yola Adamawa State, Nigeria
2 Department of Hematology, University of Benin Teaching Hospital PMB, Nigeria
3 Department of Dentistry, University of Benin Teaching Hospital PMB, Nigeria
4 Department of Microbiology, University of Benin Teaching Hospital PMB, Nigeria
Correspondence Address:
Ibeh Nnana Isaiah
Department of Medical Microbiology, Federal Medical Centre Yola Adamawa State
Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
Background: The occurrence of the different types of Extended spectrum beta Lactamase producing Escherichia coli with the, Sulphurhydryl variable, Temonera and the Cefotaximase have been on the rise Aim: The study was to determine the prevalence of extended spectrum beta lactamase gene resistance across the clinical isolates of hospitalized patients. Materials and Method: Three hundred and fifty isolates of Escherichia coli were received from different clinical specimens. The susceptibility profile of the isolates against 10 different antibiotics was examined, the MICs (Minimum Inhibitory Concentration) for ceftazidime were also determined using micro-broth dilution assay. Isolates showing MIC ≥ 6 μg/ml for ceftazidime were screened for ESBL (PCT)phenotypic confirmatory test and subjected to PCR (polymerase chain reaction) to further. Results: By disk diffusion test, there was resistance to ceftazidime and cefotaxime were 180(51.4%) and 120 (34.2%) respectively. However, all strains were susceptible to imipenem. 250 isolates showed MICs≥ 6 μg/ml for ceftazidime of which 180 (72%) were positive for extended spectrum beta lactamase. The prevalence of Sulphurhydryl variable, Temonera and the Cefotaximase among these isolates were 17.1%, 6.6% and 17%, respectively. Conclusion: For the identification of extended spectrum beta lactamase producing isolates it is recommended that clinical laboratories adopt simple test based on Cinical laboratory standard institute recommendation for confirming extended spectrum beta lactamase production in enterobacteriacea species. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
